TY - JOUR
T1 - Arrested cerebral adrenoleukodystrophy
T2 - A clinical and proton magnetic resonance spectroscopy study in three patients
AU - Korenke, G. Christoph
AU - Pouwels, Petra J.W.
AU - Frahm, Jens
AU - Hunneman, Donald H.
AU - Stoeckler, Sylvia
AU - Krasemann, Ernst
AU - Jost, Wolfram
AU - Hanefeld, Folker
PY - 1996/1/1
Y1 - 1996/1/1
N2 - We report three unrelated boys with X-linked adrenoleukodystrophy with onset of typical neurological symptoms of cerebral adrenoleukodystrophy between the age of 7 and 11 years. In contrast to the expected rapid progression, these patients showed an apparent arrest of initial neurological deterioration for subsequent periods of 5-12 years. Repeated neuroimaging revealed no progression of demyelination. Despite regional variability of demyelination, proton magnetic resonance spectroscopy revealed a specific metabolic pattern in all patients, with only moderate reduction of N- acetylaspartate, normal or reduced choline-containing compounds, normal or enhanced myo-inositol and no detectable lactate, which differs from findings in progressive cerebral adrenoleukodystrophy which usually exhibits a severe reduction of N-acetylaspartate and marked increases of choline-containing compounds, myo-inositol, and lactate. The ability to identify this newly described subgroup of patients with cerebral adrenoleukodystrophy is important for medical advice and planning of therapy.
AB - We report three unrelated boys with X-linked adrenoleukodystrophy with onset of typical neurological symptoms of cerebral adrenoleukodystrophy between the age of 7 and 11 years. In contrast to the expected rapid progression, these patients showed an apparent arrest of initial neurological deterioration for subsequent periods of 5-12 years. Repeated neuroimaging revealed no progression of demyelination. Despite regional variability of demyelination, proton magnetic resonance spectroscopy revealed a specific metabolic pattern in all patients, with only moderate reduction of N- acetylaspartate, normal or reduced choline-containing compounds, normal or enhanced myo-inositol and no detectable lactate, which differs from findings in progressive cerebral adrenoleukodystrophy which usually exhibits a severe reduction of N-acetylaspartate and marked increases of choline-containing compounds, myo-inositol, and lactate. The ability to identify this newly described subgroup of patients with cerebral adrenoleukodystrophy is important for medical advice and planning of therapy.
UR - http://www.scopus.com/inward/record.url?scp=0030249684&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/0887-8994(95)00156-5
DO - https://doi.org/10.1016/0887-8994(95)00156-5
M3 - Article
C2 - 8888042
SN - 0887-8994
VL - 15
SP - 103
EP - 107
JO - Pediatric neurology
JF - Pediatric neurology
IS - 2
ER -